Skip to content

Risk factors in retinopathy of prematurity

Risk predictors for the development of retinopathy of prematurity in very low birth weight neonates

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN15382580
Enrollment
108
Registered
2016-07-12
Start date
2008-11-14
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy of prematurity in very low birth weight neonates Eye Diseases

Interventions

The study aimed to evaluate risk factors for development of retinopathy of prematurity in preterm very low birth weight neonates. The study was a prospective, unmatched case control study conducted in

Sponsors

Trivandrum Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Preterm babies weighting less than 1.5 kg and gestational age < 34 weeks.

Exclusion criteria

Exclusion criteria: Neonates with congenital anomalies

Design outcomes

Primary

MeasureTime frame
Occurrence of retinopathy of prematurity (ROP) in very low birth weight neonates (<1500g and <34 weeks of age) at four weeks of postnatal age. The screening was conducted by an experienced ophthalmologist

Secondary

MeasureTime frame
Assessment of a significant association between ROP and both maternal and neonatal risk predictors, via statistical analysis at 18 months from start of the study. Maternal risk predictors: type of delivery, maternal fever, Pregnancy Induced Hypertension (PIH), Gestational Diabetes Mellitus (GDM), cardiac disease, Premature Rupture of Membrane (PROM), antepartum hemorrhage, chorioamnionitis, multiple pregnancy, infertility treatment, urinary tract infections (UTI), polyhydramnios and oligohydramnios. Neonatal risk predictors: gestational age, birth weight, septicemia, apnoea, anemia, hypotension, need for inotropic support, type and duration of oxygen therapy, patent ductus arteriosus (PDA), necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH) and phototherapy.

Countries

India

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026